TAKEDA PHARMACEUTICAL CO LTD Last Quarter Change: USA Stocks, Unchanged

TAKEDA PHARMACEUTICAL CO LTD quarter change: USA Stocks, Unchanged

In share positions in stocks (listed in the US), from the quarter ended 2025-06-30 to 2025-09-30, TAKEDA PHARMACEUTICAL CO LTD opened 0 positions, added to 0, reduced 0, sold out of 1 and left 6 unchanged. The largest increase in value was OVID (+$7,306,215); the largest decrease was HLVX (-$13,381,160).

OVID: Country of operation United States; Class COM; Shares 2025-06-30 7,531,996; Shares 2025-09-30 7,531,996.
EQ: Country of operation United States; Class COM; Shares 2025-06-30 1,824,977; Shares 2025-09-30 1,824,977.
STTK: Country of operation United States; Class COM; Shares 2025-06-30 515,619; Shares 2025-09-30 515,619.
AMWL: Country of operation United States; Class COM; Shares 2025-06-30 77,733; Shares 2025-09-30 77,733.

Two Form 13F-HR filings compared (SEC CIK 1395064): 2025-06-30 (filed 2025-08-08) and 2025-09-30 (filed 2025-11-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.

Stock	Country of operation	Class	Shares 2025-06-30	Shares 2025-09-30	Value 2025-06-30	Value 2025-09-30	Value change
OVID Ovid Therapeutics, Inc.	United States	COM	7,531,996	7,531,996	$2,485,380	$9,791,595	+$7,306,215
EQ Equillium, Inc.	United States	COM	1,824,977	1,824,977	$575,233	$2,609,717	+$2,034,484
STTK Shattuck Labs, Inc.	United States	COM	515,619	515,619	$408,267	$1,232,329	+$824,062
AMWL American Well Corporation	United States	COM	77,733	77,733	$691,050	$478,061	-$212,989
RANI Rani Therapeutics Holdings, Inc.	United States	COM	203,190	203,190	$104,419	$101,554	-$2,865
LAB Standard Biotools, Inc.	United States	COM	16,515	16,515	$19,818	$21,470	+$1,652

Similar Firms

Firm Name	Country	13F Value	Holdings
Not available yet